Neurology Central

Immunotherapy in glioblastoma: emerging options in precision medicine

0

Immunotherapy for glioblastoma (GBM) provides a unique opportunity for targeted therapies for each patient, addressing individual variability in genes, tumor biomarkers and clinical profile. As immunotherapy has the potential to specifically target tumor cells with minimal risk to normal tissue, several immunotherapeutic strategies are currently being evaluated in clinical trials in GBM.

To view restricted content, please:
Share:

Leave A Comment